Marek Waluga

Marek Waluga

Auto-generated profile, based on publicly available information

Marek Waluga

Department of Basic Biomedical Science, Silesian Medical University, Sosnowiec, Poland

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2010 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
Michael KuklaMichael Kukla
Michael Kukla
KZKrystyna Zwirska-Korczala
Krystyna Zwirska-Korczala
MHMarek Hartleb
Marek Hartleb
MWMarek Waluga
Marek Waluga
ACAlina Chwist
Alina Chwist
RBRafal Buldak
Rafal Buldak
Objective. Chemerin and vaspin are new adipokines which may modulate inflammatory response and insulin sensitivity in non-alcoholic fatty liver disease (NAFLD). The aims of this study were to assess: (1) circulating levels of chemerin and vaspin and their association with liver histology and markers of liver injury in NAFLD patients; and (2) the relationship between the analyzed adipokines and insulin resistance. Material and methods. A total of 41 NAFLD patients with body mass index (BMI) 30.4 ± 3.3 kg/m2 [20 with non-alcoholic steatohepatitis (NASH) and BMI 30.3 ± 3.3 kg/m2 and 21 with simple steatosis/uncertain NASH (SS/UN) and BMI 30.5 ± 3.4 kg/m2] and 10 healthy volunteers with BMI 24.0 ± 2.9 kg/m2 were included in the study. Results. Serum chemerin concentration was significantly higher in NAFLD patients compared to healthy volunteers (p = 0.009). Serum chemerin was significantly higher in patients with NASH compared to patients with SS/UN (p = 0.009). The homeostasis model assessment for insulin resistance (HOMA-IR) value was higher in patients with NASH than in patients with SS/UN (p = 0.01). Serum chemerin and HOMA-IR were positively associated with NAFLD activity score (r = 0.40, p = 0.02; and r = 0.43, p = 0.008, respectively). Serum chemerin was associated with hepatocyte ballooning degeneration (r = 0.37; p = 0.03), total cholesterol (r = 0.45; p = 0.008) and diastolic blood pressure (r = 0.41; p = 0.02). HOMA-IR was related to fibrosis stage (r = 0.51; p = 0.001) and inflammatory activity grade in portal tracts (r = 0.40; p = 0.01). Serum vaspin correlated with hepatocyte ballooning degeneration (r = 0.31; p = 0.04), alanine aminotransferase and aspartate aminotransferase (r = 0.33, p = 0.03; and r = 0.32, p = 0.04, respectively) and diastolic blood pressure (r = 0.39, p = 0.01). Conclusions. This study shows for the first time that chemerin and vaspin serum concentrations are altered in patients with NAFLD. The analyzed adipokines appear to play a pivotal role in the pathogenesis of NAFLD, not only as regulators of insulin sensitivity, but also as mediators of the inflammatory process.

1 January 2015 in World Journal of Hepatology
Verified
Journal Article
Open access
MWMarek Waluga
Marek Waluga
Michael KuklaMichael Kukla
Michael Kukla
Michael KuklaMichael Kukla
Michael Kukla
MŻMichał Żorniak
Michał Żorniak
ABAgata Bacik
Agata Bacik
RKRafał Kotulski
Rafał Kotulski
Many recent studies have examined the importance of Helicobacter pylori (H. pylori) infection in the pathogenesis of the diseases outside the stomach and explored the significance of this bacterium in the pathogenesis of some metabolic and cardiovascular diseases. Recent studies have provided evidence that H. pylori is also involved in the pathogenesis of some liver diseases. Many observations have proved that H. pylori infection is important in the development of insulin resistance, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, liver fibrosis and cirrhosis. The worsening of liver inflammation of different origins also occurs during H. pylori infection. Some studies have indicated that H. pylori infection induces autoimmunological diseases in the liver and biliary tract. The potential significance of this bacterium in carcinogenesis is unclear, but it is within the scope of interest of many studies. The proposed mechanisms through which H. pylori impacts the development of hepatobiliary diseases are complex and ambiguous. The importance of other Helicobacter species in the development of hepatobiliary diseases is also considered because they could lead to the development of inflammatory, fibrotic and necrotic injuries of the liver and, consequently, to hepatocellular carcinoma. However, many contrary viewpoints indicate that some evidence is not convincing, and further studies of the subject are needed. This review presents the current knowledge about the importance of H. pylori in the pathogenesis of liver and in biliary diseases.

1 January 2014 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MWMarek Waluga
Marek Waluga
MHMarek Hartleb
Marek Hartleb
GBGrzegorz Boryczka
Grzegorz Boryczka
Michael KuklaMichael Kukla
Michael Kukla
KZKrystyna Zwirska-Korczala
Krystyna Zwirska-Korczala
To investigate serum adipokine levels in inflammatory bowel disease (IBD) patients before treatment and after achieving clinical remission. Serum concentrations of six adipokines (tissue growth factor-β1, adiponectin, leptin, chemerin, resistin, and visfatin) were studied in 40 subjects with active IBD [24 subjects with Crohn's disease (CD) and in 16 subjects with ulcerative colitis (UC)] before and after three months of therapy with corticosteroids and/or azathioprine. Clinical diagnoses were based on ileocolonoscopy, computed tomography or magnetic resonance enterography and histological examination of mucosal biopsies sampled during endoscopy. Serum levels of adipokines were assessed by an indirect enzyme-linked immunosorbent assay. The control group was comprised of 16 age- and sex-matched healthy volunteers. Baseline leptin concentrations were significantly decreased in both types of IBD compared to controls (8.0 ± 9.1 in CD and 8.6 ± 6.3 in UC vs 16.5 ± 10.1 ng/mL in controls; P < 0.05), and significantly increased after treatment only in subjects with CD (14.9 ± 15.1 ng/mL; P < 0.05). Baseline serum resistin concentrations were significantly higher in CD (19.3 ± 12.5 ng/mL; P < 0.05) and UC subjects (23.2 ± 11.0 ng/mL; P < 0.05) than in healthy controls (10.7 ± 1.1 ng/mL). Treatment induced a decrease in the serum resistin concentration only in UC subjects (14.5 ± 4.0 ng/mL; P < 0.05). Baseline serum concentrations of visfatin were significantly higher in subjects with CD (23.2 ± 3.2 ng/mL; P < 0.05) and UC (18.8 ± 5.3 ng/mL; P < 0.05) than in healthy controls (14.1 ± 5.3 ng/mL). Treatment induced a decrease in the serum visfatin concentrations only in CD subjects (20.4 ± 4.8 ng/mL; P < 0.05). Serum levels of adiponectin, chemerin and tissue growth factor-β1 did not differ between CD and UC subjects compared to healthy controls and also were not altered by anti-inflammatory therapy. Clinical indices of IBD activity did not correlate with adipokine levels. IBD modulates serum adipokine levels by increasing resistin and visfatin release and suppressing leptin production.

1 November 2009 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
Michael KuklaMichael Kukla
Michael Kukla
KZK. Zwirska-Korczala
K. Zwirska-Korczala
AGA. Gabriel
A. Gabriel
MWM. Waluga
M. Waluga
IWI. Warakomska
I. Warakomska
WKW. Kryczka
W. Kryczka

12 March 2010 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
Michael KuklaMichael Kukla
Michael Kukla
KŻK. Żwirska-Korczala
K. Żwirska-Korczala
AGA. Gabriel
A. Gabriel
MWM. Waluga
M. Waluga
IWI. Warakomska
I. Warakomska
WKW. Kryczka
W. Kryczka

1 January 2015 in Clinical and Experimental Hepatology
Verified
Journal Article
Open access
Michael KuklaMichael Kukla
Michael Kukla
DPDamian Piotrowski
Damian Piotrowski
MWMarek Waluga
Marek Waluga
MHMarek Hartleb
Marek Hartleb
Chronic hepatitis C (CHC) is generally a slowly progressive disease, but some factors associated with rapid progression have been identified. Hepatitis C virus (HCV) may contribute to a broad spectrum of metabolic disturbances – namely, steatosis, insulin resistance (IR), increased prevalence...